Metropolitan Life Insurance CO Tenaya Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.88 - $6.8 $7,994 - $18,876	2,776 New	2,776 $14,000
Q2 2023 Aug 10, 2023	BUY	$2.64 - $7.64 $6,882 - $19,917	2,607 New	2,607 $15,000
Q2 2022 Aug 11, 2022	SELL	$5.01 - $14.12 $10,991 - $30,979	-2,194 Closed	0 $0
Q1 2022 Jun 20, 2023	BUY	$9.41 - $19.3 $20,645 - $42,344	2,194 New	2,194 $25,000
Q1 2022 Mar 30, 2023	SELL	$9.41 - $19.3 $21,050 - $43,174	-2,237 Reduced 50.49%	2,194 $25,000
Q1 2022 May 12, 2022	SELL	$9.41 - $19.3 $21,050 - $43,174	-2,237 Reduced 50.49%	2,194 $26,000
Q4 2021 Jun 21, 2023	BUY	$18.41 - $29.58 $81,574 - $131,068	4,431 New	4,431 $83,000
Q3 2021 Jun 21, 2023	BUY	$15.35 - $26.66 $68,015 - $118,130	4,431 New	4,431 $91,000
Q3 2021 Mar 30, 2023	BUY	$15.35 - $26.66 $68,015 - $118,130	4,431 New	4,431 $91,000
Q3 2021 Nov 15, 2021	BUY	$15.35 - $26.66 $68,015 - $118,130	4,431 New	4,431 $92,000

56.4M

900

400

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $51.7M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.